Tracking MMP-9 levels in serum has the potential to contribute to early detection, prognosis, and evaluation of therapeutic responses across various forms of epilepsy, establishing it as a promising biomarker in clinical diagnostics [30,31,32]. The gene discussed is MMP9; the disease is epilepsy.